Welcome to the World ADC media hub. Here you will find exclusive insights from our expert speakers, past presentations and articles plus much more.
Email adc@hansonwade.com if you submit for approval content that you wish to share.
Newly Added!
An Exclusive Speaker Interview With…
Radek Spisek, Chief Executive Officer, SOTIO
The Rise and Rise of mRNA
By the Medicine Maker, World ADC San Diego Media Partner
An Exclusive Speaker Interview With Byondis:
- Ruud Coumans, Project Leader, Antibody-Drug Conjugates
- Patrick Groothuis, Principal Scientist, In Vivo Pharmacology, Toxicology, Drug Metabolism & Pharmacokinetic
- Evelyn Van Den Tweel, Project Leader, Clinical Development
An Exclusive Speaker Interview With:
Amy Peterson, Executive Vice President & Chief Development Officer, CytomX
ADC Magazine
Goodwin Biotechnology Poster
ADC London Post Event Report
Speaker Interview
Antibody Drug Conjugates Clinical E-Book
Abzena announces 20m$ investment
2017 Post Event Report
Past Presentations
ADCs with two bundles of chelator groups of
radionuclides for theranostic applications
Assessing Phase 1 Interim Data of
MORAb-202, a Folate Receptor
Alpha-Targeted Antibody-Drug
Conjugate
Toshimitsu Uenaka.
Linker Design: Why so complex? – GNF
Bernhard Geierstanger
Clinical Development of ADCs: ARX788, a Her2-targeting ADC as an Example – Ambrx
Yong-jiang Hei, M.D., Ph.D.
Novel Warheads for Targeted Therapies of Cancer - pro-PBDs: from Design to Clinical Candidates
Iontcho R. Vlahov, PhD
VP of Discovery Chemistry
Endocyte, Inc., West Lafayette, IN, USA
